11:30 – 12:45
Rooms 203 + 204

Melbourne Convention and
Exhibition Centre (MCEC), Australia

Faculty:   Dr Nigel Key (Chair)
  Proffesor Ingrid Pabinger-Fasching,
  Dr Elena Santagostino,
  Dr Hanspeter Rottensteiner,
  Dr Werner Höllriegl,
  Dr Geoff Allen

The expert faculty will:

  • Share insights into vector design and gene expression plus discuss the potential impact, implications, and applicability of these novel technologies for patients with hemophilia
  • Assess emerging preclinical data and highlight key milestones in Takeda’s gene therapy program for patients with hemophilia
  • Consider the identification of appropriate potential candidates for gene therapy